...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Infectious disease clinics of North America >Parasitic Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient, Including Toxoplasmosis and Strongyloidiasis
【24h】

Parasitic Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient, Including Toxoplasmosis and Strongyloidiasis

机译：干细胞移植受体和血液学恶性患者的寄生感染，包括弓形虫病和抗弓形虫病

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Hematopoietic stem cell transplantation (HSCT) recipients may infrequently develop parasitic infections at the time of the procedure via contamination from allograft tissue or blood products, and in the post transplantation period through the traditional route of infection or as a reactivation caused by immunosuppression related to the transplant. To reduce risk, efforts should be directed at performing a comprehensive history, maintaining a high index of suspicion, and adhering to preventive measures. Additional strategies for the prevention, screening and careful follow-up, identification, and pre-emptive treatment of parasitic infections are required to reduce morbidity and mortality in HSCT patients.
机译：造血干细胞移植（HSCT）受者可以通过来自同种异体移植组织或血液制品的污染，并通过传统的感染途径或作为由免疫抑制引起的重新激活，在手术后的过程中不经常发育寄生虫感染。 移植。 为了减少风险，应努力执行全面的历史，维持高度怀疑，并遵守预防措施。 预防，筛查和仔细随访，鉴定和寄生虫治疗的额外策略是降低HSCT患者的发病率和死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号